British drug maker GSK is set to open its individual patient data pertaining to the clinical trials of an array of medicines, which will enable researchers to leverage them in their specific scientific purposes. The drug company, which ...
Tags: Clinical Trials, GSK
The National Development and Reform Commission is pestering and probing 60 foreign drug makers regarding the prices at which they sell their wares in China. Scrutiny of the foreign drug sector in China made headlines in June when ...
Tags: Harsh Medicine, Pharma Firms
British drug-maker GlaxoSmithKline (GSK) has reached settlement with the attorneys general of eight US states over misleading marketing of the diabetes treatment drug, Avandia, and even agreed to pay $229m to settle the lawsuits. Without ...
Tags: Avandia Lawsuits, Medicine
GlaxoSmithKline (GSK) has reported a profit attributable to shareholders of £1.04bn, or 21.2 pence per diluted share, for the second quarter (Q2) of 2013 compared to £1.24bn, or 24.7 pence in 2012. Cost of sales for the second ...
Tags: Glaxosmithkline, Net Profit
GlaxoSmithKline (GSK) has announced Health Canada approval of a BRAF-inhibitor, Tafinlar, and a first in class MEK-inhibitor, Mekinist, for melanoma patients with BRAF V600 mutation. Both, Tafinlar (dabrafenib mesylate) and Mekinist ...
Tags: Melanoma Drugs, Medicine
UK-based GlaxoSmithKline (GSK) has postponed plans to increase its stake from 46.4% to 75% in GlaxoSmithKline Consumer Nigeria (GSK Nigeria), proposed under a scheme of arrangement. The minority shareholders considered the deal ...
UK health and social care guidance body NICE has again rejected GlaxoSmithKline's (GSK) belimumab (Benlysta) as an add-on therapy in adults with active, autoantibody-positive systemic lupus erythematosus (SLE). Commenting on the second ...
GlaxoSmithKline (GSK) is mulling to establish a joint venture (JV) with a Chinese company as part of its vaccine strategy of teaming up with local partners. The plans come at a time when the company is facing corruption and tax laws ...
Tags: Vaccine Research, GSK
Mergers and acquisitions in the UK food and drink industry hit a 10-year low at just 73 deals in the first half of this year, revealed figures from information services company Experian. Could AG Barr's acquisition of GSK's Lucozade and ...
Tags: Agriculture, Food
The USFDA has cleared Actavis' abbreviated new drug application (ANDA) for Lamotrigine orally disintegrating tablets, 25mg, 50mg, 100mg and 200mg. A generic version of GlaxoSmithKline's Lamictal ODT, the antiepileptic drug is indicated ...
GlaxoSmithKline (GSK) and Theravance have withdrawn license application for the use of inhaled drug fluticasone furoate (FF) and vilanterol (VI), with proposed brand name of Relvar Ellipta, as treatment for chronic obstructive pulmonary ...
Tags: Japan, GSK, Relvar License
Some vintners in Italy last week may have stopped stomping grapes and frantically opened their Chinese dictionaries. The vineyards in the EU's wine-producing regions have 10 days to get the language down pat, so they can respond to a trade ...
Tags: China Probe, EU Wineries
SelecTech, Inc. has recently announced that its signature commercial and industrial static control flooring systems have tested to be the "best in class." In a recent scientific test study conducted by a renowned, independent static ...
Tags: Construction, Decoration
China’s National Development and Reform Commission (NDRC) has launched a probe into drug pricing at 60 domestic and international pharmaceutical companies, as the country expands its healthcare coverage, Financial Times reported. The ...
Tags: Drugmakers, Medicine
A combination of GlaxoSmithKline’s GSK744 and J&J’s TMC278 monthly injection therapy, designed to evaluate its potential to control HIV, is currently being tested. Results of a study, which was conducted on 40 HIV-negative ...
Tags: Injection Therapy, Medicine